Kimberly Lee, DO

Kimberly Lee, DO has extensive experience in corporate affairs, communications, and investor relations. Kimberly is currently serving as the Chief Corporate Affairs Officer at Taysha Gene Therapies since 2022. Prior to this, they held the role of SVP, Corporate Communications and Investor Relations at Taysha Gene Therapies from 2020 to 2021. From 2017 to 2020, they worked at Lexicon Pharmaceuticals, Inc. as the Head of Corporate Strategy and Investor Relations. Before that, they were the Vice President of Corporate Strategy, Corporate Communications, and Investor Relations at Raptor Pharmaceuticals (acquired by Horizon Pharma) from 2014 to 2017. Kimberly also worked as a Managing Director and Senior Equity Research Analyst at Janney Montgomery Scott LLC from 2012 to 2014 and ThinkEquity LLC in 2012. Kimberly'sprevious experience includes roles as Vice President and Senior Equity Research Analyst at Pacific Growth Equities (acquired by Wedbush Securities) from 2007 to 2010 and Equity Research Associate at Pacific Growth Equities and Jefferies from 2006 to 2007 and 2003 to 2005 respectively. Kimberly started their career as an Equity Research Associate at Stephens in 2001.

Kimberly Lee, DO, obtained a Bachelor of Science degree in Biological Sciences from Stanford University. Following their undergraduate studies, they attended Kirksville College of Osteopathic Medicine to pursue a Doctor of Osteopathy degree.